Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT in patients with transthyretin cardiac amyloidosis: optimization and correlation with cardiac functional parameters

Satoru Watanabe, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroto Yoneyama, Takahiro Konishi, Anri Inaki, Shohei Yoshida, Junji Komatsu and Seigo Kinuya
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 137;
Satoru Watanabe
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenichi Nakajima
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Wakabayashi
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroto Yoneyama
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Konishi
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anri Inaki
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shohei Yoshida
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junji Komatsu
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seigo Kinuya
1Kanazawa University Hospital Kanazawa Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

137

Introduction: Volumetric evaluation of 99mTechnetium-pyrophosphate (99mTc-PYP) SPECT/CT is an objective and useful method for diagnosing transthyretin cardiac amyloidosis (ATTR-CA), but the method has not been standardized. The aim of this study was to optimize the method of volumetric evaluation and to assess its relationship to other quantitative PYP evaluation and cardiac functional parameters.

Methods: We retrospectively evaluated 43 patients who underwent 99mTc-PYP SPECT/CT at our hospital between October 2018 and October 2020. All patients underwent endomyocardial biopsies (EMB; n = 37) and/or TTR gene tests (n = 20). Twenty (47%) patients were diagnosed with ATTR-CA (10 wild types and 10 hereditary types), and 23 (53%) patients with non-ATTR (control: 1 light chain cardiac amyloidosis, 1 cardiac sarcoidosis, and 21 other myocardial disorders; all control patients underwent EMB and were negative for ATTR amyloid). Patients were imaged at 1 hour (n = 18) or 3 hours (n = 25) after 99mTc-PYP injection using both SPECT/CT and planar studies. First, we evaluated an aortic blood pool 99mTc-PYP activity (ABPmax) using SUVmax in the ascending aorta at the level of the pulmonary artery bifurcation. Next, we objectively evaluated the total volume of the region where 99mTc-PYP uptake > 1.0×, 1.2×, and 1.4× of ABPmax within the left and right ventricular myocardium and defined as cardiac metabolic volume (CMVABP1.0, CMVABP1.2, and CMVABP1.4: volume of voxels with abnormal 99mTc-PYP uptakes). SUV and CMV were calculated using xSPECT Quant (Siemens). We compared CMV to cardiac metabolic activity (CMA: CMV×SUVmean within the abnormal 99mTc-PYP uptake region) and a conventional quantitative parameter (planar heart to contralateral ratio of 99mTc-PYP uptakes: H/CL). Accuracy for identifying ATTR-CA was examined by receiver operating characteristic analysis and the area under the curve (AUC) was calculated. Correlation of quantitative 99mTc-PYP scintigraphy metrics with brain natriuretic peptide (BNP) and left ventricular ejection fraction (LVEF) were measured.

Results: CMVABP1.2 achieved the highest sensitivity and specificity of 90% and 100%, respectively (Figure). AUC of CMVABP1.0, CMVABP1.2, CMVABP1.4, CMAABP1.2, and H/CL were 0.96, 0.95, 0.90, 0.93, and 0.93 (p = ns), respectively. In patients with ATTR-CA (n = 20), CMVABP1.2 strongly correlated with CMAABP1.2 (r = 0.97, p < 0.0001), moderately correlated with H/CL (r = 0.58, p = 0.008) and BNP (r = 0.45, p = 0.045), and moderately negatively correlated with LVEF (r = -0.61, p = 0.005). However, H/CL did not correlate with BNP and LVEF. CMVABP1.2 did not differ between patients with wild type ATTR-CA and hereditary type ATTR-CA. Although ABPmax was significantly lower in 3-hour image compared with 1-hour image (p = 0.0003), in subgroup analysis the accuracy was similar for identifying ATTR-CA between patients imaged at 1 hour (AUC = 0.92) and 3 hours (AUC = 0.96). CMVABP1.2 showed the highest sensitivity and specificity for identifying ATTR-CA at both timings. ABPmax did not correlate with CMVABP1.2, BNP, and LVEF. While ABPmax moderately and negatively correlated with estimated glomerular filtration rate in patients imaged at 3 hours (r = -0.48, p = 0.01), it did not at 1 hour.

Conclusions: CMVABP1.2 could identify patients with ATTR-CA more accurately than other CMV and H/CL, and strongly correlated with CMA. Although CMV significantly correlated with cardiac functional parameters, H/CL did not.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT in patients with transthyretin cardiac amyloidosis: optimization and correlation with cardiac functional parameters
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT in patients with transthyretin cardiac amyloidosis: optimization and correlation with cardiac functional parameters
Satoru Watanabe, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroto Yoneyama, Takahiro Konishi, Anri Inaki, Shohei Yoshida, Junji Komatsu, Seigo Kinuya
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 137;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT in patients with transthyretin cardiac amyloidosis: optimization and correlation with cardiac functional parameters
Satoru Watanabe, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroto Yoneyama, Takahiro Konishi, Anri Inaki, Shohei Yoshida, Junji Komatsu, Seigo Kinuya
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 137;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Quantitative Myocardial Blood Flow and Reserve with Low Dose Rest/High Dose Stress Regadenoson PET/CT-MPI: The Utility of Residual Activity Correction With N-13 Ammonia
  • Machine learning improves interpretation of coronary artery disease using Rb-82 PET quantification of myocardial blood flow
  • Integrating deep-learning based segmentation and ‘fast’ voxel-level dosimetry tools to enable automated real-time patient specific dosimetry
Show more Oral - PhysicianPharm

Cardiovascular Molecular Imaging

  • Preliminary characterization of 68Ga-FAPI-46 for molecular imaging of cardiac fibroblast activation
  • The Area of Fibroblast Activation Exceeds the Hypoperfused Infarct Region in Patients with Acute Myocardial Infarction
Show more Cardiovascular Molecular Imaging

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire